Insiders · SPRY

Eric Karas

Chief Commercial Officer at ARS Pharmaceuticals, Inc. (SPRY) since November 2022

Eric Karas has filed 13 insider reports with the SEC since November 2022, as chief Commercial Officer at ARS Pharmaceuticals, Inc. (SPRY). In the last 12 months Eric Karas sold $250K of stock on the open market. In the latest filing, on June 13, 2026, Eric Karas sold 25,000 shares of ARS Pharmaceuticals, Inc. (SPRY) for $250K at an average of $10.00.

Filings
13
Companies
1
Bought on market
None
Sold on market
$1.31M

Companies where Eric Karas is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
ARS Pharmaceuticals, Inc. logo
SPRY
ARS Pharmaceuticals, Inc.
Chief Commercial Officersince November 202212,176$1.31M$3.36Jun 13, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Eric Karas with

Other insiders at the same companies

Questions about Eric Karas

What is Eric Karas's role at ARS Pharmaceuticals, Inc.?
Eric Karas reports to the SEC as chief Commercial Officer at ARS Pharmaceuticals, Inc. (SPRY), according to the latest filing on June 13, 2026.
How many shares does Eric Karas own?
After the latest filing that states it, Eric Karas directly owned 12,176 shares of ARS Pharmaceuticals, Inc. (SPRY). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Eric Karas bought or sold stock recently?
The most recent open-market sale was on June 12, 2026: sold 25,000 shares of ARS Pharmaceuticals, Inc. (SPRY) for $250K at an average of $10.00.
How do I get alerts when Eric Karas files?
Follow Eric Karas on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Eric Karas (SEC CIK 0001951287). Totals count each trade once, skipping amendments whose original is on file, from Nov 10, 2022 on. View on SEC EDGAR · Get this as JSON